Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00075049Phase 2Completed
Phase 2, randomised, double-blind trial of RTS,S in malaria (2 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Safety and reactogenicity of the candidate vaccine. Started Dec 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00075049.